Followers | 47 |
Posts | 12038 |
Boards Moderated | 0 |
Alias Born | 09/12/2017 |
![](https://investorshub.advfn.com/uicon/633016.png?cb=1702783483)
Friday, April 05, 2024 12:44:19 PM
Please point that out with link included.
I found the Principal Investigator list so why didnt CYDY want to divulge a designated PI on the main Study page?---
Contacts/Locations
Central Contact Person
Name
Kush Dhody, MBBS, MS, CCRA
Telephone
301-956-2536
Email
kushd@amarexcro.com
Study Officials
Location
Alexander City, Alabama, United States, 35010
Status:
Recruiting
Facility:
Advanced Cardiovascular, LLC
Contact:
Contact
Sabrina Forbus, RN, BSN
256-215-5323
Principal Investigator
William Ross Davis, MD
Fullerton, California, United States, 92835
Status:
Recruiting
Facility:
St. Jude Medical Center
Contact:
Contact
Blanca Sanchez
714-446-5620
Blanca.Sanchez@stjoe.org
Principal Investigator
David J Park, MD
Los Angeles, California, United States, 90095
Status:
Recruiting
Facility:
UCLA
Contact:
Contact
Nancy Lopez
310-794-8043
NancyRLopez@mednet.ucla.edu
Principal Investigator
Otto Yang, MD
Tampa, Florida, United States, 33612
Status:
Recruiting
Facility:
James A. Haley Veterans' Hospital
Contact:
Contact
Adam Zoble
813-631-3671
Adam.Zoble@va.gov
Principal Investigator
Koushik Reddy, MD
Gainesville, Georgia, United States, 30501
Status:
Active, not recruiting
Facility:
Center for Advanced Research & Education (CARE)
Boston, Massachusetts, United States, 02215
Status:
Recruiting
Facility:
Beth Israel Deaconess Medical Center
Contact:
Contact
Caitlin Davis
617-735-4466
Cdavis6@bidmc.harvard.edu
Principal Investigator
Sabrina Tan, MD
Livingston, New Jersey, United States, 07052
Status:
Recruiting
Facility:
St. Barnabas
Contact:
Principal Investigator
Subroto Paul, MD
Morristown, New Jersey, United States, 07962-1905
Status:
Recruiting
Facility:
Atlantic Health System Hospital
Contact:
Principal Investigator
Eric Whitman, MD
Teaneck, New Jersey, United States, 07666
Status:
Recruiting
Facility:
Holy Name Medical Center
Contact:
Contact
Patty Kiledjian
201-541-6312
pkiledjian@holyname.org
Principal Investigator
Benjamin De La Rosa, MD
Bronx, New York, United States, 10467
Status:
Recruiting
Facility:
Montefiore Medical Center
Contact:
Contact
Jane Wilson
718-920-7916
Principal Investigator
Harish Seethamraju, MD
Brooklyn, New York, United States, 11229
Status:
Recruiting
Facility:
New York Community Hospital of Brooklyn
Contact:
Contact
Marina Bilik
718-692-5336
mbilik@nych.com
Principal Investigator
Isaia Avraham, MD
Winston-Salem, North Carolina, United States, 27103
Status:
Recruiting
Facility:
Novant Health
Contact:
Contact
Shannon Bowman
shannon.bowman@novanthealth.org
Contact
Pailing Richards
704-996-7627
pcrichards@novanthealth.org
Principal Investigator
Michael Morgan, MD
Columbus, Ohio, United States, 43215
Status:
Recruiting
Facility:
Ohio Health
Contact:
Principal Investigator
Kiran Devulapally, MD
Corvallis, Oregon, United States, 97330
Status:
Recruiting
Facility:
Good Samaritan Hospital Corvallis
Contact:
Contact
Stephanie Mock
541-768-4352
stmock@samhealth.org
Principal Investigator
Brian Delmonaco, MD
Portland, Oregon, United States, 97239
Status:
Recruiting
Facility:
Oregon Health and Sciences University
Contact:
Principal Investigator
Marcel Curlin, MD
Dallas, Texas, United States, 75204
Status:
Recruiting
Facility:
Baylor Scott & White Research Institute
Contact:
Contact
Samantha Wang
Samantha.wang@bswhealth.org
Principal Investigator
Uriel Sandkovsky
Houston, Texas, United States, 77030
Status:
Recruiting
Facility:
Baylor College of Medicine
Contact:
Contact
Hinali Zaveri, MD
713-873-2353
hzaveri@bcm.edu
Principal Investigator
Kalpalatha Guntupalli, MD
Houston, Texas, United States, 77030
Status:
Recruiting
Facility:
University of Texas
Contact:
Contact
Jordan Lake
713-500-6767
Jordan.e.lake@uth.tmc.edu
Principal Investigator
Jordan Lake, MD
https://www.clinicaltrials.gov/study/NCT04347239?intr=leronlimab&rank=8&tab=history&a=13#contacts-locations-card
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM